Progress in Neuro-Psychopharmacology and Biological PsychiatryGeneticsPeer-reviewed journal article
Genome-wide association meta-analysis of cocaine dependence: shared genetics with comorbid conditions
Judit Cabana‐DomíngueziD, Anu ShivalikanjliiD, Noèlia Fernàndez-castillo AiD, Bru CormandiD
Abstract
Cocaine dependence is a complex psychiatric disorder that is highly comorbid with other psychiatric traits. Twin and adoption studies suggest that genetic variants contribute substantially to cocaine dependence susceptibility, which has an estimated heritability of 65-79%. Here we performed a meta-analysis of genome-wide association studies of cocaine dependence using four datasets from the dbGaP repository (2,085 cases and 4,293 controls, all of them selected by their European ancestry). Although no genome-wide significant hits were found in the SNP-based analysis, the gene-based analysis identified HIST1H2BD as associated with cocaine-dependence (10% FDR). This gene is located in a region on chromosome 6 enriched in histone-related genes, previously associated with schizophrenia (SCZ). Furthermore, we performed LD Score regression analysis with comorbid conditions and found significant genetic correlations between cocaine dependence and SCZ, ADHD, major depressive disorder (MDD) and risk taking. We also found, through polygenic risk score analysis, that all tested phenotypes can significantly predict cocaine dependence status: SCZ (R2=2.28%; P=1.21e-26), ADHD (R2=1.39%; P=4.5e-17), risk taking (R2=0.60%; P=2.7e-08), MDD (R2=1.21%; P=4.35e-15), childrens aggressiveness (R2=0.3%; P=8.8e-05) and antisocial behavior (R2=1.33%; P=2.2e-16). To our knowledge, this is the largest reported cocaine dependence GWAS meta-analysis in European-ancestry individuals. We identified suggestive associations in regions that may be related to cocaine dependence and found evidence for shared genetic risk factors between cocaine dependence and several comorbid psychiatric traits. However, the sample size is limited and further studies are needed to confirm these results.
- organism: human
- assay: GWAS summary statistics
- research focus: GWAS / association mapping
- approach: statistical model
- Citations
- 73
- FWCI
- 1.17
- Field percentile
- top 24%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Multi-ancestral genome-wide association study of clinically defined nicotine dependence reveals strong genetic correlations with other substance use disorders and health-related traits.
Emma C. Johnson, Dongbing Lai, … Arpana Agrawal A·Psychological MedicinePeer-reviewed·Jan 1, 2025
- Genome-wide association study of cocaine self-administration behavior in Heterogeneous Stock rats
Montana Kay Lara, Lieselot L. G. Carrette, … Olivier George·Nature CommunicationsPeer-reviewed·Jun 11, 2026
- Association Between Substance Use Disorder And Polygenic Liability To Schizophrenia
Sarah M. Hartz, Amy C. Horton, … Laura Jean Bierut·Biological PsychiatryPeer-reviewed·Jun 6, 2017
- Pleiotropic genetic architecture linking schizophrenia and substance use disorders
Selena Aranda, Dóra Koller, … Bru Cormand·medRxiv·Sep 4, 2026
- Genome-wide association analysis of lifetime cannabis use (N=184,765) identifies new risk loci, genetic overlap with mental health, and a causal influence of schizophrenia on cannabis use
Joëlle A. Pasman, Karin J. H. Verweij, … Jacqueline M. Vink·bioRxiv·Jan 8, 2018
- Disentangling the shared genetics of ADHD, cannabis use disorder and cannabis use and prediction of cannabis use disorder in ADHD
Trine Tollerup Nielsen, Jinjie Duan, … Ditte Demontis·medRxiv·Feb 22, 2024